Plasmapheresis

Physical removal of IgM from circulation

Response rate
Immediate symptomatic relief
Onset
Hours
Route
IV (therapeutic plasma exchange)
Line
Adjunct
IgM effect
Acute reduction (temporary)

Evidence summary

Emergency treatment for symptomatic hyperviscosity syndrome. Rapidly reduces IgM and serum viscosity. Effect is temporary; definitive therapy must follow. Also used before rituximab in patients with high IgM to prevent IgM flare. Essential component of acute WM management.